Bristol-Myers Squibb Co
BMYNYSEPharmaceuticals
$60.57
Up+$1.29 (+2.18%)today
Market closed · refreshes every 30sLast trade Oct 15, 4:00 PM EDT
Key stats
- Open
- $60.67
- Previous close
- $59.28
- Day range
- $60.39 – $62.25
- 52-week range
- $42.52 – $68.64
- Market cap
- $123.73B
- P/E ratio
- 13.53
- Dividend yield
- 4.58%
- Beta
- 0.19
News about BMY
- YahooHow Has Merck's Story Changed?
Investors are pricing Merck (MRK) stock at 5.5 times sales, compared with 3.1 for the S&P 500. Shareholders paying that premium need to understand exactly what they hold, and the drugmaker's priorities have changed. During the fiscal Q4 2024 call in February 2025, executives noted that conditions for the GARDASIL vaccine in China remained challenging. By the August 4, 2026 call, management emphasized something else. So what does management talk up now.
- YahooCan Gilead's Deal With VIR Boost Its Oncology Pipeline and Growth?
Gilead Sciences expands its oncology pipeline through a Vir Biotechnology deal worth up to $1.74 billion in additional milestones, targeting three novel cancer therapies.
- YahooBristol-Myers Squibb's Pulmonary Fibrosis Treatment Still Viable Despite Recent Mixed Phase 3 Results, UBS Says
Bristol-Myers Squibb's (BMY) LPA1 antagonist admilparant can still be viable despite recent mixed re
- YahooA $600,000 Dividend Portfolio Has a $52,900 Tax Problem. Here’s the Roth Solution
Six popular dividend stocks sitting in a taxable account quietly hand a portion of every payout to the IRS, and the gap between what you earn and what you keep widens sharply depending on which bracket you occupy and which account holds the shares.
Your position
Sign in to track your BMY shares and return.
Add to portfolioAbout
- Exchange
- NYSE
- Industry
- Pharmaceuticals
- Listed
- 1980-03-17